Found 25 matching trials
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C
PHASE3This study is to evaluate the overall efficacy, and safety profile of the t...
Location
Novartis Investigative Site
The Changes of Cytokines During Antiviral Therapy
NAPegylated interferon α-2a(Peg-IFN-α) not only inhibit viral replication, bu...
Location
Beijing Ditan hospital,Capital Medical University
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation
PHASE2Evaluation of efficacy of triple therapy with pegylated interferon, ribavir...
Location
Haut-Lévêque Hospital
Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
PHASE4Patients with chronic hepatitis C with persistently normal alanine aminotra...
Location
Università degli Studi di Torino - Azienda Ospedaliera San Giovanni Battista di Torino, Molinette,
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
N/AThis is a multi-center, open-label clinical study. This study was aimed to ...
Location
Multiple Locations
To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs.
NAThe study is to guide clinical cure of peginterferon alfa-2a treatment in p...
Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss
NAFor HBeAg (+) hepatitis B patients who have been treated by entecavir for 4...
Location
The Third Affliated Hospital of Sun Yat-sen University
Malaysia Stop Tyrosine Kinase Inhibitor Trial
PHASE3To compare administration of peginterferon-α-2a for 1 year versus observati...
Location
Sultanah Aminah Hospital
An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy
PHASE3The purpose of this study is to investigate the effectiveness and safety of...
Location
Multiple Locations
Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1
PHASE3This study will assess the safety and efficacy of alisporivir (ALV) and boc...
Location
Novartis Investigational Site